Clinical Trials Browser

Interventional × Flucytosine × Gastrointestinal × Clear all

NCT03724071 2023-06-23

Study of TG6002 (VV TK-RR-FCU1) in Combination With 5-FC in Patients With Advanced Gastro-intestinal Tumors.

Phase 1/2 Terminated

Gastrointestinal

Digestive System Neoplasms, Colorectal Neoplasms

NCT04194034 2023-06-23

Study of Intrahepatic Arterial Infusion of TG6002 in Combination With 5-FC in Patients With Metastatic Colorectal Cancer

Phase 1/2 Terminated

Gastrointestinal

Colorectal Neoplasms

NCT04195373 2020-11-25

A Safety Study of TMV-018 in Patients With Tumors of the Gastrointestinal Tract

Phase 1 Withdrawn

Gastrointestinal

Esophageal Neoplasms, Gastrointestinal Neoplasms, Stomach Neoplasms, Colorectal Neoplasms

NCT02576665 2020-02-07

A Study of Toca 511, a Retroviral Replicating Vector, Combined With Toca FC in Patients With Solid Tumors or Lymphoma (Toca 6)

Phase 1 Terminated

BreastCNSDermatologicGastrointestinalGenitourinaryGynecologicHead & NeckLymphoidSarcomaThoracic

Astrocytoma, Urinary Bladder Neoplasms, Carcinoma, Non-Small-Cell Lung, Glioblastoma, Head and Neck Neoplasms, Lymphoma, Melanoma, Ovarian Neoplasms, Pancreatic Neoplasms, Sarcoma, Colorectal Neoplasms, Triple Negative Breast Neoplasms

NCT00978107 2014-07-16

Trial of TG4023 Combined With Flucytosine in Liver Tumors

Phase 1 Completed

Gastrointestinal

Carcinoma, Hepatocellular, Colorectal Neoplasms